Health
23andMe Jumps as CEO Floats Taking DNA Tester Private
- Wojcicki tells board she seeks to remain in control of company
- Company is under pressure as stock price remains below $1
This article is for subscribers only.
DNA testing firm 23andMe Holding Co.’s shares soared after Chief Executive Officer Anne Wojcicki said she’s considering taking the struggling company private, less than three years after it began selling shares.
Wojcicki told board members she is proposing to acquire the company in a potential go-private transaction, according to a filing with the Securities and Exchange Commission. The stock, which has traded below $1 a share since late last year, rose as much as 33% on Thursday, the biggest jump since August 2022, before paring some of the gain.